ORIC Pharmaceuticals, Inc.
ORIC
$12.19
-$0.03-0.25%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.09% | -7.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.78% | -6.13% | |||
| Operating Income | 5.78% | 6.13% | |||
| Income Before Tax | 6.39% | 10.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.39% | 10.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.39% | 10.36% | |||
| EBIT | 5.78% | 6.13% | |||
| EBITDA | 5.91% | 6.12% | |||
| EPS Basic | 9.69% | 29.23% | |||
| Normalized Basic EPS | 9.67% | 29.23% | |||
| EPS Diluted | 9.69% | 29.23% | |||
| Normalized Diluted EPS | 9.67% | 29.23% | |||
| Average Basic Shares Outstanding | 3.67% | 26.66% | |||
| Average Diluted Shares Outstanding | 3.67% | 26.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||